Eledon Pharmaceuticals Inc Working Capital to Net Assets Ratio
Eledon Pharmaceuticals Inc working capital to net assets ratio. Eledon Pharmaceuticals Inc (ELDN) has a Working Capital to Net Assets ratio of 85.8% as of December 2025. Working capital of $117.34 Million (current assets of $135.69 Million minus current liabilities of $18.34 Million) is measured against net assets of $136.78 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ELDN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Eledon Pharmaceuticals Inc (2012–2025)
Working capital to net assets ratio of Eledon Pharmaceuticals Inc from 2012 to 2025. This chart shows how Eledon Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 85.8%, reflecting working capital of $117.34 Million against net assets of $136.78 Million USD. See ELDN defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Eledon Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2012–2025)
Eledon Pharmaceuticals Inc working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Eledon Pharmaceuticals Inc from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Eledon Pharmaceuticals Inc (ELDN) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 85.8% | $117.34 Million | $136.78 Million | $135.69 Million | $18.34 Million | ▼ -26.1 pp |
| 2024 | 111.9% | $132.15 Million | $118.14 Million | $143.73 Million | $11.58 Million | ▲ +49.2 pp |
| 2023 | 62.6% | $52.23 Million | $83.42 Million | $56.13 Million | $3.90 Million | ▼ -0.4 pp |
| 2022 | 63.0% | $53.04 Million | $84.18 Million | $59.52 Million | $6.47 Million | ▲ +11.8 pp |
| 2021 | 51.2% | $83.94 Million | $164.00 Million | $88.35 Million | $4.40 Million | ▼ -8.2 pp |
| 2020 | 59.4% | $113.15 Million | $190.60 Million | $115.63 Million | $2.48 Million | ▼ -32.0 pp |
| 2019 | 91.4% | $8.65 Million | $9.46 Million | $9.97 Million | $1.32 Million | ▲ +10.4 pp |
| 2018 | 81.0% | $11.74 Million | $14.49 Million | $14.28 Million | $2.53 Million | ▼ -9.2 pp |
| 2017 | 90.3% | $17.56 Million | $19.45 Million | $19.00 Million | $1.44 Million | ▼ -9.2 pp |
| 2016 | 99.5% | $26.72 Million | $26.86 Million | $29.54 Million | $2.82 Million | ▲ +0.7 pp |
| 2015 | 98.8% | $61.01 Million | $61.72 Million | $67.17 Million | $6.16 Million | ▼ -0.9 pp |
| 2014 | 99.8% | $103.27 Million | $103.50 Million | $107.51 Million | $4.24 Million | ▲ +154.0 pp |
| 2013 | -54.2% | $29.97 Million | $-55.27 Million | $32.18 Million | $2.21 Million | ▼ -29.4 pp |
| 2012 | -24.8% | $9.91 Million | $-39.90 Million | $11.93 Million | $2.02 Million | — |